Ascentage Pharma Group International
AAPG | NASDAQ
$16.19
+$0.33 (+2.08%)
Sep 22, 2026, 11:38 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -807.68M | -639.96M | -1.18B | -568.43M | 163M | -523.29M | -409.58M | -443.59M | -420.52M | -416.12M | -416.12M |
Depreciation & Amortization | 42.88M | 41.9M | 6.04M | 45.86M | 47.31M | 47.62M | 45.58M | 4.56M | 31.04M | 2.2M | 14.52M |
Stock-Based Compensation | n/a | n/a | 26.1M | 12.19M | 8.73M | 13.25M | 18.25M | 16.53M | 11.05M | 20.03M | 23.49M |
Other Working Capital | n/a | n/a | n/a | 15.04M | n/a | 29.24M | 82.98M | 42.81M | 42.81M | 123.78M | 123.78M |
Other Non-Cash Items | 164.22M | -181.6M | 702.88M | 640.33M | -609.33M | 170.35M | -155.97M | 34.48M | -40.45M | 82.59M | -78.57M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | 87.36M | n/a | -69.01M | 59.87M | 52.21M | 52.21M | 94.83M | 94.83M |
Operating Cash Flow | -600.58M | -779.66M | -452.56M | 217.31M | -390.29M | -361.07M | -441.86M | -335.8M | -366.66M | -216.49M | -361.86M |
Capital Expenditures | -11.73M | -7.75M | -20.04M | -7.76M | -16.53M | -12.13M | -44.71M | -118.48M | -118.48M | -218.31M | -218.31M |
Cash Acquisitions | 1.98K | -765.44K | -42.8M | -9.52M | n/a | -20M | 1.49M | -10M | -10M | -18.1M | -18.1M |
Purchase of Investments | -2.97M | -294M | -633.11M | -29.82M | -115.56M | 30.66M | -31.35M | -65M | -65M | -891.91M | -891.91M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 96.65M | n/a | n/a | n/a | 894.89M | 894.89M |
Other Investing Acitivies | 934.86M | -13.99 | -8 | -218.04M | -116.78K | -7.97M | 8.39M | -50.11M | 29.21M | 759.61M | -771.22M |
Investing Cash Flow | 920.17M | -302.52M | -695.7M | -235.32M | -132.21M | 87.21M | -56.93M | -226.76M | -147.43M | 526.79M | -1B |
Debt Repayment | 110.94M | 262.63M | 49.68M | -44.47M | -98.85M | 115.82M | -13.36M | 347.94M | 347.94M | 274.29M | 274.29M |
Common Stock Repurchased | -7.74M | 1.39K | -9.2M | 1.98M | -1.96M | -5.92M | -1K | -13.39M | -13.39M | -12.94M | -12.94M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.55M | -7.2M | -14.19M | -13.72M | 533.91M | -179.43M | 65.47M | -171.72M | 148.48M | -199.43M | 172.7M |
Financial Cash Flow | 98.65M | 1.6B | 964.7M | -53.39M | 433.1M | -69.53M | 522.2M | 162.83M | 483.03M | 712.25M | 1.08B |
Net Cash Flow | 729.23M | -419.13M | 760.37M | -187.6M | 11.68M | -481.05M | 157.69M | -361.25M | -361.25M | 655.08M | 686.91M |
Free Cash Flow | -612.31M | -787.41M | -452.16M | 235.27M | -370.92M | -369.75M | -413.18M | -445.44M | -445.44M | -520.65M | -520.65M |
Adj. Free Cash Flow | -612.31M | -787.41M | -478.25M | 223.08M | -379.65M | -383M | -431.42M | -461.97M | -456.49M | -540.68M | -544.14M |
Maintenance CapEx | -11.73M | n/a | -20.04M | n/a | n/a | -12.13M | n/a | n/a | n/a | -44.85M | -84.24M |
Growth CapEx | n/a | -7.75M | n/a | -7.76M | -16.53M | n/a | -44.71M | -118.48M | -118.48M | -173.46M | -134.08M |
Owner Earnings | -612.31M | -779.66M | -452.16M | 243.03M | -354.39M | -369.74M | -368.47M | -326.96M | -326.96M | -347.19M | -386.58M |
Add to Watchlist
Select watchlists to add or remove AAPG